...
首页> 外文期刊>European journal of cancer care >Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer
【24h】

Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer

机译:验证墨西哥西班牙语版本的EORTC QLQ-C30和BR23问卷,以评估墨西哥乳腺癌女性与健康相关的生活质量

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to validate the Mexican-Spanish version of The European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR23 questionnaire. The translation procedure followed EORTC guidelines. QLQ-C30 and QLQ-BR23 instruments were completed by Mexican women with breast cancer, attending a teaching referral cancer centre from February 2009 to January 2010. Patients were divided in two groups: (1) Patients with early stage of breast cancer; and (2) Patients with locally advanced breast cancer (LABC). Reliability and validity tests were performed, and validity over time (responsiveness) was conducted in a subset of patients. Two hundred and thirty-four women (mean age, 52.3 years) completed both questionnaires. Convergent and divergent validity was adequate. Cronbach's alpha of all multi-item scales showed values ≥0.7 except for Cognitive and Breast symptoms scales (0.52 and 0.65 respectively). Patients with early stages (n= 77) showed better functional scores and lower symptoms scores than patients with LABC (n= 157). Score means variation after responsiveness analysis demonstrated high sensitivity to change after breast cancer surgery. The Mexican-Spanish version of the EORTC QLQ-BR23 questionnaire is a valid and suitable instrument to estimate HRQL in patients with breast cancer.
机译:这项研究的目的是验证欧洲癌症研究和治疗组织(EORTC)QLQ-BR23问卷的墨西哥西班牙语版本。翻译程序遵循EORTC指南。 QLQ-C30和QLQ-BR23仪器由墨西哥患有乳腺癌的妇女完成,于2009年2月至2010年1月在教学转诊癌症中心就诊。患者分为两组:(1)乳腺癌早期患者; (2)局部晚期乳腺癌(LABC)患者。进行了可靠性和有效性测试,并对一部分患者进行了一段时间的有效性(反应性)研究。 234名女性(平均年龄52.3岁)填写了两个问卷。收敛和发散的有效性是足够的。除认知和乳房症状量表(分别为0.52和0.65)外,所有多项目量表的Cronbach's alpha值均≥0.7。早期患者(n = 77)比LABC患者(n = 157)表现出更好的功能评分和更低的症状评分。分数表示反应性分析后的变异表明对乳腺癌手术后的变化具有高度敏感性。 EORTC QLQ-BR23问卷的墨西哥西班牙语版本是评估乳腺癌患者HRQL的有效且合适的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号